Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 32UNKNOWN 1OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 1Breast 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 4sintilimab 2pembrolizumab 2anlotinib 2Aprepitant 2nimotuzumab 1nabiximols 1camrelizumab 1apatinib 1Radiotherapy, Intensity-Modulated 1Platinum Compounds 1Palonosetron 1Paclitaxel 1Ondansetron 1Olanzapine 1Gemcitabine 1Drug Therapy 1Dexamethasone 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × nimotuzumab × Head & Neck × Clear all
NCT03915132 2021-01-29

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

ChineseAMS

Phase 2 Unknown
47 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡